A deep learning framework with an embedded-based feature selection approach for the early detection of the Alzheimer's disease

Mild cognitive impairment detection from facial video interviews by applying spatial-to-temporal attention module

Early detection of Mild Cognitive Impairment (MCI) leads to early interventions to slow the progression from MCI into dementia. Deep Learning (DL) algorithms could help achieve early non-invasive and low-cost detection of MCI. This paper presents the detection of MCI in older adults using DL models based only on facial features extracted from video-recorded conversations at home. We used the data collected from the I-CONECT behavioral intervention study (NCT02871921), where several sessions of semi-structured interviews between socially isolated older individuals and interviewers were video recorded. We develop a framework that extracts holistic spatial facial features using a convolutional autoencoder and temporal information using transformers. We proposed the Spatial-to-Temporal Attention Module (STAM) to detect the I-CONECT study participants' cognitive conditions (MCI vs. those with normal cognition (NC)) using facial and interaction features. The interaction features of the facial features improved the prediction performance compared with applying facial features solely. The detection accuracy using this combined method reached 88%, whereas the accuracy without applying the segments and sequences information of the facial features within a video on a certain theme was 84%. Overall, the results show that spatiotemporal facial features modeled using DL algorithms have a discriminating power for the detection of MCI.

Deep Learning for Alzheimer's Disease Prediction: A Comprehensive Review

Alzheimer's disease (AD) is a neurological disorder that significantly impairs cognitive function, leading to memory loss and eventually death. AD progresses through three stages: early stage, mild cognitive impairment (MCI) (middle stage), and dementia. Early diagnosis of Alzheimer's disease is crucial and can improve survival rates among patients. Traditional methods for diagnosing AD through regular checkups and manual examinations are challenging. Advances in computer-aided diagnosis systems (CADs) have led to the development of various artificial intelligence and deep learning-based methods for rapid AD detection. This survey aims to explore the different modalities, feature extraction methods, datasets, machine learning techniques, and validation methods used in AD detection. We reviewed 116 relevant papers from repositories including Elsevier (45), IEEE (25), Springer (19), Wiley (6), PLOS One (5), MDPI (3), World Scientific (3), Frontiers (3), PeerJ (2), Hindawi (2), IO Press (1), and other multiple sources (2). The review is presented in tables for ease of reference, allowing readers to quickly grasp the key findings of each study. Additionally, this review addresses the challenges in the current literature and emphasizes the importance of interpretability and explainability in understanding deep learning model predictions. The primary goal is to assess existing techniques for AD identification and highlight obstacles to guide future research.

Progress and trends in neurological disorders research based on deep learning

In recent years, deep learning (DL) has emerged as a powerful tool in clinical imaging, offering unprecedented opportunities for the diagnosis and treatment of neurological disorders (NDs). This comprehensive review explores the multifaceted role of DL techniques in leveraging vast datasets to advance our understanding of NDs and improve clinical outcomes. Beginning with a systematic literature review, we delve into the utilization of DL, particularly focusing on multimodal neuroimaging data analysis-a domain that has witnessed rapid progress and garnered significant scientific interest. Our study categorizes and critically analyses numerous DL models, including Convolutional Neural Networks (CNNs), LSTM-CNN, GAN, and VGG, to understand their performance across different types of Neurology Diseases. Through particular analysis, we identify key benchmarks and datasets utilized in training and testing DL models, shedding light on the challenges and opportunities in clinical neuroimaging research. Moreover, we discuss the effectiveness of DL in real-world clinical scenarios, emphasizing its potential to revolutionize ND diagnosis and therapy. By synthesizing existing literature and describing future directions, this review not only provides insights into the current state of DL applications in ND analysis but also covers the way for the development of more efficient and accessible DL techniques. Finally, our findings underscore the transformative impact of DL in reshaping the landscape of clinical neuroimaging, offering hope for enhanced patient care and groundbreaking discoveries in the field of neurology. This review paper is beneficial for neuropathologists and new researchers in this field.

A bilateral filtering-based image enhancement for Alzheimer disease classification using CNN

This study aims to develop an optimally performing convolutional neural network to classify Alzheimer's disease into mild cognitive impairment, normal controls, or Alzheimer's disease classes using a magnetic resonance imaging dataset. To achieve this, we focused the study on addressing the challenge of image noise, which impacts the performance of deep learning models. The study introduced a scheme for enhancing images to improve the quality of the datasets. Specifically, an image enhancement algorithm based on histogram equalization and bilateral filtering techniques was deployed to reduce noise and enhance the quality of the images. Subsequently, a convolutional neural network model comprising four convolutional layers and two hidden layers was devised for classifying Alzheimer's disease into three (3) distinct categories, namely mild cognitive impairment, Alzheimer's disease, and normal controls. The model was trained and evaluated using a 10-fold cross-validation sampling approach with a learning rate of 0.001 and 200 training epochs at each instance. The proposed model yielded notable results, such as an accuracy of 93.45% and an area under the curve value of 0.99 when trained on the three classes. The model further showed superior results on binary classification compared with existing methods. The model recorded 94.39%, 94.92%, and 95.62% accuracies for Alzheimer's disease versus normal controls, Alzheimer's disease versus mild cognitive impairment, and mild cognitive impairment versus normal controls classes, respectively.

Identification of gene-level methylation for disease prediction

DNA methylation is an epigenetic alteration that plays a fundamental part in governing gene regulatory processes. The DNA methylation mechanism affixes methyl groups to distinct cytosine residues, influencing chromatin architectures. Multiple studies have demonstrated that DNA methylation's regulatory effect on genes is linked to the beginning and progression of several disorders. Researchers have recently uncovered thousands of phenotype-related methylation sites through the epigenome-wide association study (EWAS). However, combining the methylation levels of several sites within a gene and determining the gene-level DNA methylation remains challenging. In this study, we proposed the supervised UMAP Assisted Gene-level Methylation method (sUAGM) for disease prediction based on supervised UMAP (Uniform Manifold Approximation and Projection), a manifold learning-based method for reducing dimensionality. The methylation values at the gene level generated using the proposed method are evaluated by employing various feature selection and classification algorithms on three distinct DNA methylation datasets derived from blood samples. The performance has been assessed employing classification accuracy, F-1 score, Mathews Correlation Coefficient (MCC), Kappa, Classification Success Index (CSI) and Jaccard Index. The Support Vector Machine with the linear kernel (SVML) classifier with Recursive Feature Elimination (RFE) performs best across all three datasets. From comparative analysis, our method outperformed existing gene-level and site-level approaches by achieving 100% accuracy and F1-score with fewer genes. The functional analysis of the top 28 genes selected from the Parkinson's disease dataset revealed a significant association with the disease.

The increasing instance of negative emotion reduce the performance of emotion recognition

Introduction

Emotion recognition plays a crucial role in affective computing. Recent studies have demonstrated that the fuzzy boundaries among negative emotions make recognition difficult. However, to the best of our knowledge, no formal study has been conducted thus far to explore the effects of increased negative emotion categories on emotion recognition.

Methods

A dataset of three sessions containing consistent non-negative emotions and increased types of negative emotions was designed and built which consisted the electroencephalogram (EEG) and the electrocardiogram (ECG) recording of 45 participants.

Results

The results revealed that as negative emotion categories increased, the recognition rates decreased by more than 9%. Further analysis depicted that the discriminative features gradually reduced with an increase in the negative emotion types, particularly in the θ, α, and β frequency bands.

Discussion

This study provided new insight into the balance of emotion-inducing stimuli materials.

Potential Ocular Biomarkers for Early Detection of Alzheimer's Disease and Their Roles in Artificial Intelligence Studies

Alzheimer's disease (AD) is the leading cause of dementia worldwide. Early detection is believed to be essential to disease management because it enables physicians to initiate treatment in patients with early-stage AD (early AD), with the possibility of stopping the disease or slowing disease progression, preserving function and ultimately reducing disease burden. The purpose of this study was to review prior research on the use of eye biomarkers and artificial intelligence (AI) for detecting AD and early AD. The PubMed database was searched to identify studies for review. Ocular biomarkers in AD research and AI research on AD were reviewed and summarized. According to numerous studies, there is a high likelihood that ocular biomarkers can be used to detect early AD: tears, corneal nerves, retina, visual function and, in particular, eye movement tracking have been identified as ocular biomarkers with the potential to detect early AD. However, there is currently no ocular biomarker that can be used to definitely detect early AD. A few studies that used AI with ocular biomarkers to detect AD reported promising results, demonstrating that using AI with ocular biomarkers through multimodal imaging could improve the accuracy of identifying AD patients. This strategy may become a screening tool for detecting early AD in older patients prior to the onset of AD symptoms.

CGUFS: A clustering-guided unsupervised feature selection algorithm for gene expression data

Aim

Gene expression data is typically high dimensional with a limited number of samples and contain many features that are unrelated to the disease of interest. Existing unsupervised feature selection algorithms primarily focus on the significance of features in maintaining the data structure while not taking into account the redundancy among features. Determining the appropriate number of significant features is another challenge.

Method

In this paper, we propose a clustering-guided unsupervised feature selection (CGUFS) algorithm for gene expression data that addresses these problems. Our proposed algorithm introduces three improvements over existing algorithms. For the problem that existing clustering algorithms require artificially specifying the number of clusters, we propose an adaptive k-value strategy to assign appropriate pseudo-labels to each sample by iteratively updating a change function. For the problem that existing algorithms fail to consider the redundancy among features, we propose a feature grouping strategy to group highly redundant features. For the problem that the existing algorithms cannot filter the redundant features, we propose an adaptive filtering strategy to determine the feature combinations to be retained by calculating the potentially effective features and potentially redundant features of each feature group.

Result

Experimental results show that the average accuracy (ACC) and matthews correlation coefficient (MCC) indexes of the C4.5 classifier on the optimal features selected by the CGUFS algorithm reach 74.37% and 63.84%, respectively, significantly superior to the existing algorithms.

Conclusion

Similarly, the average ACC and MCC indexes of the Adaboost classifier on the optimal features selected by the CGUFS algorithm are significantly superior to the existing algorithms. In addition, statistical experiment results show significant differences between the CGUFS algorithm and the existing algorithms.

A feature selection framework for anxiety disorder analysis using a novel multiview harris hawk optimization algorithm

Machine learning (ML) has demonstrated its ability to exploit important relationships within data collection, which can be used in the diagnosis, treatment, and prediction of outcomes in a variety of clinical contexts. Anxiety mental disorder analysis is one of the pending difficulties that ML can help with. A thorough study is demanded to gain a better understanding of this illness. Since the anxiety data is generally multidimensional, which complicates processing and as a result of technology improvements, medical data from several perspectives, known as multiview data (MVD), is being collected. Each view has its own data type and feature values, so there is a lot of diversity. This work introduces a novel preprocessing feature selection (FS) approach, multiview harris hawk optimization (MHHO), which has the potential to reduce the dimensionality of anxiety data, hence reducing analytical effort. The uniqueness of MHHO originates from combining a multiview linking methodology with the power of the harris hawk optimization (HHO) method. The HHO is used to identify the lowest optimal MVD feature subset, while multiview linking is utilized to find a promising fitness function to direct the HHO FS while accounting for all data views' heterogeneity. The complexity of MHHO is O(THL2), where T is the number of iterations, H is the number of involved harris hawks, and L is the number of objects. Using two publicly available anxiety MVDs, MHHO is validated against ten recent rivals in its category. The experimental findings show that MHHO has a considerable advantage in terms of convergence speed (converging in less than ten iterations), subset size (removing 75% of the views; reducing feature size by 66%), and classification accuracy (approaching 100%). Furthermore, statistical analyses reveal that MHHO is statistically different from its competitors, bolstering its applicability. Finally, feature importance is evaluated, shedding light on the most anxiety-inducing characteristics. The likelihood of developing additional disorders (such as depression or stress) is also investigated.

Conv-Swinformer: Integration of CNN and shift window attention for Alzheimer's disease classification

Deep learning (DL) algorithms based on brain MRI images have achieved great success in the prediction of Alzheimer's disease (AD), with classification accuracy exceeding even that of the most experienced clinical experts. As a novel feature fusion method, Transformer has achieved excellent performance in many computer vision tasks, which also greatly promotes the application of Transformer in medical images. However, when Transformer is used for 3D MRI image feature fusion, existing DL models treat the input local features equally, which is inconsistent with the fact that adjacent voxels have stronger semantic connections than spatially distant voxels. In addition, due to the relatively small size of the dataset for medical images, it is difficult to capture local lesion features in limited iterative training by treating all input features equally. This paper proposes a deep learning model Conv-Swinformer that focuses on extracting and integrating local fine-grained features. Conv-Swinformer consists of a CNN module and a Transformer encoder module. The CNN module summarizes the planar features of the MRI slices, and the Transformer module establishes semantic connections in 3D space for these planar features. By introducing the shift window attention mechanism in the Transformer encoder, the attention is focused on a small spatial area of the MRI image, which effectively reduces unnecessary background semantic information and enables the model to capture local features more accurately. In addition, the layer-by-layer enlarged attention window can further integrate local fine-grained features, thus enhancing the model's attention ability. Compared with DL algorithms that indiscriminately fuse local features of MRI images, Conv-Swinformer can fine-grained extract local lesion features, thus achieving better classification results.

Classification of Alzheimer's disease using robust TabNet neural networks on genetic data

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases and its onset is significantly associated with genetic factors. Being the capabilities of high specificity and accuracy, genetic testing has been considered as an important technique for AD diagnosis. In this paper, we presented an improved deep learning (DL) algorithm, namely differential genes screening TabNet (DGS-TabNet) for AD binary and multi-class classifications. For performance evaluation, our proposed approach was compared with three novel DLs of multi-layer perceptron (MLP), neural oblivious decision ensembles (NODE), TabNet as well as five classical machine learnings (MLs) including decision tree (DT), random forests (RF), gradient boosting decision tree (GBDT), light gradient boosting machine (LGBM) and support vector machine (SVM) on the public data set of gene expression omnibus (GEO). Moreover, the biological interpretability of global important genetic features implemented for AD classification was revealed by the Kyoto encyclopedia of genes and genomes (KEGG) and gene ontology (GO). The results demonstrated that our proposed DGS-TabNet achieved the best performance with an accuracy of 93.80% for binary classification, and with an accuracy of 88.27% for multi-class classification. Meanwhile, the gene pathway analyses demonstrated that there existed two most important global genetic features of AVIL and NDUFS4 and those obtained 22 feature genes were partially correlated with AD pathogenesis. It was concluded that the proposed DGS-TabNet could be used to detect AD-susceptible genes and the biological interpretability of susceptible genes also revealed the potential possibility of being AD biomarkers.

Learning high-order interactions for polygenic risk prediction

Within the framework of precision medicine, the stratification of individual genetic susceptibility based on inherited DNA variation has paramount relevance. However, one of the most relevant pitfalls of traditional Polygenic Risk Scores (PRS) approaches is their inability to model complex high-order non-linear SNP-SNP interactions and their effect on the phenotype (e.g. epistasis). Indeed, they incur in a computational challenge as the number of possible interactions grows exponentially with the number of SNPs considered, affecting the statistical reliability of the model parameters as well. In this work, we address this issue by proposing a novel PRS approach, called High-order Interactions-aware Polygenic Risk Score (hiPRS), that incorporates high-order interactions in modeling polygenic risk. The latter combines an interaction search routine based on frequent itemsets mining and a novel interaction selection algorithm based on Mutual Information, to construct a simple and interpretable weighted model of user-specified dimensionality that can predict a given binary phenotype. Compared to traditional PRSs methods, hiPRS does not rely on GWAS summary statistics nor any external information. Moreover, hiPRS differs from Machine Learning-based approaches that can include complex interactions in that it provides a readable and interpretable model and it is able to control overfitting, even on small samples. In the present work we demonstrate through a comprehensive simulation study the superior performance of hiPRS w.r.t. state of the art methods, both in terms of scoring performance and interpretability of the resulting model. We also test hiPRS against small sample size, class imbalance and the presence of noise, showcasing its robustness to extreme experimental settings. Finally, we apply hiPRS to a case study on real data from DACHS cohort, defining an interaction-aware scoring model to predict mortality of stage II-III Colon-Rectal Cancer patients treated with oxaliplatin.

A framework to distinguish healthy/cancer renal CT images using the fused deep features

Introduction

Cancer happening rates in humankind are gradually rising due to a variety of reasons, and sensible detection and management are essential to decrease the disease rates. The kidney is one of the vital organs in human physiology, and cancer in the kidney is a medical emergency and needs accurate diagnosis and well-organized management.

Methods

The proposed work aims to develop a framework to classify renal computed tomography (CT) images into healthy/cancer classes using pre-trained deep-learning schemes. To improve the detection accuracy, this work suggests a threshold filter-based pre-processing scheme, which helps in removing the artefact in the CT slices to achieve better detection. The various stages of this scheme involve: (i) Image collection, resizing, and artefact removal, (ii) Deep features extraction, (iii) Feature reduction and fusion, and (iv) Binary classification using five-fold cross-validation.

Results and discussion

This experimental investigation is executed separately for: (i) CT slices with the artefact and (ii) CT slices without the artefact. As a result of the experimental outcome of this study, the K-Nearest Neighbor (KNN) classifier is able to achieve 100% detection accuracy by using the pre-processed CT slices. Therefore, this scheme can be considered for the purpose of examining clinical grade renal CT images, as it is clinically significant.

Wearable sensors and features for diagnosis of neurodegenerative diseases: A systematic review

Objective

Neurodegenerative diseases affect millions of families around the world, while various wearable sensors and corresponding data analysis can be of great support for clinical diagnosis and health assessment. This systematic review aims to provide a comprehensive overview of the existing research that uses wearable sensors and features for the diagnosis of neurodegenerative diseases.

Methods

A systematic review was conducted of studies published between 2015 and 2022 in major scientific databases such as Web of Science, Google Scholar, PubMed, and Scopes. The obtained studies were analyzed and organized into the process of diagnosis: wearable sensors, feature extraction, and feature selection.

Results

The search led to 171 eligible studies included in this overview. Wearable sensors such as force sensors, inertial sensors, electromyography, electroencephalography, acoustic sensors, optical fiber sensors, and global positioning systems were employed to monitor and diagnose neurodegenerative diseases. Various features including physical features, statistical features, nonlinear features, and features from the network can be extracted from these wearable sensors, and the alteration of features toward neurodegenerative diseases was illustrated. Moreover, different kinds of feature selection methods such as filter, wrapper, and embedded methods help to find the distinctive indicator of the diseases and benefit to a better diagnosis performance.

Conclusions

This systematic review enables a comprehensive understanding of wearable sensors and features for the diagnosis of neurodegenerative diseases.

An evaluation model for children's foot & ankle deformity severity using sparse multi-objective feature selection algorithm

Foot & ankle deformity is a chronic disease with high incidence and is best treated in childhood. However, the current diagnostic procedures rely on doctor's consultation and empirical judgment, and lack objective and quantitative evaluation methods, resulting in low screening rates. To solve this problem, this paper aims to construct an evaluation model for children's foot & ankle deformity through data mining and machine learning technologies. Firstly, it proposes the grading rules for children's foot & ankle deformity severity based on analyzing the existing quantitative indexes and expert experience. Then the 3D foot scanner is used to collect the sample data including 30 foot structure indexes. Finally, an advanced sparse multi-objective evolutionary algorithm (sparse MO-FS) is present for feature selection. The effectiveness of the proposed sparse MO-FS and its search efficiency are proved by comparing 8 feature selection methods and 7 search strategies. Using sparse MO-FS, foot length, arch index, ankle index, and hallux valgus index are selected, which not only simplifies the evaluation model but also improves the average classification accuracy of random forest to more than 98%.

Multi-modal feature selection with anchor graph for Alzheimer's disease

In Alzheimer's disease, the researchers found that if the patients were treated at the early stage of the disease, it could effectively delay the development of the disease. At present, multi-modal feature selection is widely used in the early diagnosis of Alzheimer's disease. However, existing multi-modal feature selection algorithms focus on learning the internal information of multiple modalities. They ignore the relationship between modalities, the importance of each modality and the local structure in the multi-modal data. In this paper, we propose a multi-modal feature selection algorithm with anchor graph for Alzheimer's disease. Specifically, we first use the least square loss and l2,1−norm to obtain the weight of the feature under each modality. Then we embed a modal weight factor into the objective function to obtain the importance of each modality. Finally, we use anchor graph to quickly learn the local structure information in multi-modal data. In addition, we also verify the validity of the proposed algorithm on the published ADNI dataset.

An optimized features selection approach based on Manta Ray Foraging Optimization (MRFO) method for parasite malaria classification

Malaria is a serious and lethal disease that has been reported by the World Health Organization (WHO), with an estimated 219 million new cases and 435,000 deaths globally. The most frequent malaria detection method relies mainly on the specialists who examine the samples under a microscope. Therefore, a computerized malaria diagnosis system is required. In this article, malaria cell segmentation and classification methods are proposed. The malaria cells are segmented using a color-based k-mean clustering approach on the selected number of clusters. After segmentation, deep features are extracted using pre-trained models such as efficient-net-b0 and shuffle-net, and the best features are selected using the Manta-Ray Foraging Optimization (MRFO) method. Two experiments are performed for classification using 10-fold cross-validation, the first experiment is based on the best features selected from the pre-trained models individually, while the second experiment is performed based on the selection of best features from the fusion of extracted features using both pre-trained models. The proposed method provided an accuracy of 99.2% for classification using the linear kernel of the SVM classifier. An empirical study demonstrates that the fused features vector results are better as compared to the individual best-selected features vector and the existing latest methods published so far.

Establishment and Analysis of a Combined Diagnostic Model of Alzheimer's Disease With Random Forest and Artificial Neural Network

Alzheimer's disease (AD) is a neurodegenerative condition that causes cognitive decline over time. Because existing diagnostic approaches for AD are limited, improving upon previously established diagnostic models based on genetic biomarkers is necessary. Firstly, four AD gene expression datasets were collected from the Gene Expression Omnibus (GEO) database. Two datasets were used to establish diagnostic models, and the other two datasets were used to verify the model effect. We merged GSE5281 with GSE44771 as the training dataset and found 120 DEGs. Then, we used random forest (RF) to screen 6 key genes (KLF15, MAFF, ITPKB, SST, DDIT4, and NRXN3) as being critical for separating AD and normal samples. The weights of these key genes were measured, and a diagnostic model was created using an artificial neural network (ANN). The area under the curve (AUC) of the model is 0.953, while the accuracy is 0.914. In the final step, two validation datasets were utilized to assess AUC performance. In GSE109887, our model had an AUC of 0.854, and in GSE132903, it had an AUC of 0.810. To summarize, we successfully identified key gene biomarkers and developed a new AD diagnostic model.

Early-Stage Alzheimer's Disease Categorization Using PET Neuroimaging Modality and Convolutional Neural Networks in the 2D and 3D Domains

Alzheimer's Disease (AD) is a health apprehension of significant proportions that is negatively impacting the ageing population globally. It is characterized by neuronal loss and the formation of structures such as neurofibrillary tangles and amyloid plaques in the early as well as later stages of the disease. Neuroimaging modalities are routinely used in clinical practice to capture brain alterations associated with AD. On the other hand, deep learning methods are routinely used to recognize patterns in underlying data distributions effectively. This work uses Convolutional Neural Network (CNN) architectures in both 2D and 3D domains to classify the initial stages of AD into AD, Mild Cognitive Impairment (MCI) and Normal Control (NC) classes using the positron emission tomography neuroimaging modality deploying data augmentation in a random zoomed in/out scheme. We used novel concepts such as the blurring before subsampling principle and distant domain transfer learning to build 2D CNN architectures. We performed three binaries, that is, AD/NC, AD/MCI, MCI/NC and one multiclass classification task AD/NC/MCI. The statistical comparison revealed that 3D-CNN architecture performed the best achieving an accuracy of 89.21% on AD/NC, 71.70% on AD/MCI, 62.25% on NC/MCI and 59.73% on AD/NC/MCI classification tasks using a five-fold cross-validation hyperparameter selection approach. Data augmentation helps in achieving superior performance on the multiclass classification task. The obtained results support the application of deep learning models towards early recognition of AD.

A3C-TL-GTO: Alzheimer Automatic Accurate Classification Using Transfer Learning and Artificial Gorilla Troops Optimizer

Alzheimer's disease (AD) is a chronic disease that affects the elderly. There are many different types of dementia, but Alzheimer's disease is one of the leading causes of death. AD is a chronic brain disorder that leads to problems with language, disorientation, mood swings, bodily functions, memory loss, cognitive decline, mood or personality changes, and ultimately death due to dementia. Unfortunately, no cure has yet been developed for it, and it has no known causes. Clinically, imaging tools can aid in the diagnosis, and deep learning has recently emerged as an important component of these tools. Deep learning requires little or no image preprocessing and can infer an optimal data representation from raw images without prior feature selection. As a result, they produce a more objective and less biased process. The performance of a convolutional neural network (CNN) is primarily affected by the hyperparameters chosen and the dataset used. A deep learning model for classifying Alzheimer's patients has been developed using transfer learning and optimized by Gorilla Troops for early diagnosis. This study proposes the A3C-TL-GTO framework for MRI image classification and AD detection. The A3C-TL-GTO is an empirical quantitative framework for accurate and automatic AD classification, developed and evaluated with the Alzheimer's Dataset (four classes of images) and the Alzheimer's Disease Neuroimaging Initiative (ADNI). The proposed framework reduces the bias and variability of preprocessing steps and hyperparameters optimization to the classifier model and dataset used. Our strategy, evaluated on MRIs, is easily adaptable to other imaging methods. According to our findings, the proposed framework was an excellent instrument for this task, with a significant potential advantage for patient care. The ADNI dataset, an online dataset on Alzheimer's disease, was used to obtain magnetic resonance imaging (MR) brain images. The experimental results demonstrate that the proposed framework achieves 96.65% accuracy for the Alzheimer's Dataset and 96.25% accuracy for the ADNI dataset. Moreover, a better performance in terms of accuracy is demonstrated over other state-of-the-art approaches.

An enhanced binary Rat Swarm Optimizer based on local-best concepts of PSO and collaborative crossover operators for feature selection

In this paper, an enhanced binary version of the Rat Swarm Optimizer (RSO) is proposed to deal with Feature Selection (FS) problems. FS is an important data reduction step in data mining which finds the most representative features from the entire data. Many FS-based swarm intelligence algorithms have been used to tackle FS. However, the door is still open for further investigations since no FS method gives cutting-edge results for all cases. In this paper, a recent swarm intelligence metaheuristic method called RSO which is inspired by the social and hunting behavior of a group of rats is enhanced and explored for FS problems. The binary enhanced RSO is built based on three successive modifications: i) an S-shape transfer function is used to develop binary RSO algorithms; ii) the local search paradigm of particle swarm optimization is used with the iterative loop of RSO to boost its local exploitation; iii) three crossover mechanisms are used and controlled by a switch probability to improve the diversity. Based on these enhancements, three versions of RSO are produced, referred to as Binary RSO (BRSO), Binary Enhanced RSO (BERSO), and Binary Enhanced RSO with Crossover operators (BERSOC). To assess the performance of these versions, a benchmark of 24 datasets from various domains is used. The proposed methods are assessed concerning the fitness value, number of selected features, classification accuracy, specificity, sensitivity, and computational time. The best performance is achieved by BERSOC followed by BERSO and then BRSO. These proposed versions are comparatively assessed against 25 well-regarded metaheuristic methods and five filter-based approaches. The obtained results underline their superiority by producing new best results for some datasets.

Artificial Intelligence and Circulating Cell-Free DNA Methylation Profiling: Mechanism and Detection of Alzheimer's Disease

Background: Despite extensive efforts, significant gaps remain in our understanding of Alzheimer’s disease (AD) pathophysiology. Novel approaches using circulating cell-free DNA (cfDNA) have the potential to revolutionize our understanding of neurodegenerative disorders. Methods: We performed DNA methylation profiling of cfDNA from AD patients and compared them to cognitively normal controls. Six Artificial Intelligence (AI) platforms were utilized for the diagnosis of AD while enrichment analysis was used to elucidate the pathogenesis of AD. Results: A total of 3684 CpGs were significantly (adj. p-value < 0.05) differentially methylated in AD versus controls. All six AI algorithms achieved high predictive accuracy (AUC = 0.949−0.998) in an independent test group. As an example, Deep Learning (DL) achieved an AUC (95% CI) = 0.99 (0.95−1.0), with 94.5% sensitivity and specificity. Conclusion: We describe numerous epigenetically altered genes which were previously reported to be differentially expressed in the brain of AD sufferers. Genes identified by AI to be the best predictors of AD were either known to be expressed in the brain or have been previously linked to AD. We highlight enrichment in the Calcium signaling pathway, Glutamatergic synapse, Hedgehog signaling pathway, Axon guidance and Olfactory transduction in AD sufferers. To the best of our knowledge, this is the first reported genome-wide DNA methylation study using cfDNA to detect AD.

POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability

Mass spectrometry-based proteomic technique has become indispensable in current exploration of complex and dynamic biological processes. Instrument development has largely ensured the effective production of proteomic data, which necessitates commensurate advances in statistical framework to discover the optimal proteomic signature. Current framework mainly emphasizes the generalizability of the identified signature in predicting the independent data but neglects the reproducibility among signatures identified from independently repeated trials on different sub-dataset. These problems seriously restricted the wide application of the proteomic technique in molecular biology and other related directions. Thus, it is crucial to enable the generalizable and reproducible discovery of the proteomic signature with the subsequent indication of phenotype association. However, no such tool has been developed and available yet. Herein, an online tool, POSREG, was therefore constructed to identify the optimal signature for a set of proteomic data. It works by (i) identifying the proteomic signature of good reproducibility and aggregating them to ensemble feature ranking by ensemble learning, (ii) assessing the generalizability of ensemble feature ranking to acquire the optimal signature and (iii) indicating the phenotype association of discovered signature. POSREG is unique in its capacity of discovering the proteomic signature by simultaneously optimizing its reproducibility and generalizability. It is now accessible free of charge without any registration or login requirement at https://idrblab.org/posreg/.